| Financial Year |
March 31 2022 |
| Monetary Funds |
436,881,171.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,515,199,771.92 |
| Advances to Suppliers |
268,566,090.09 |
| Other Receivables |
-- |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
503,055.56 |
| Dividend Receivable |
-- |
| Inventories |
83,321,027.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,915,586.77 |
| Total Current Assets |
2,753,321,398.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,271,006.12 |
| Investment Properties |
34,371,275.01 |
| Fixed Assetes |
789,002,649.20 |
| Under-construction Projects |
29,255,635.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,255,785.57 |
| R&D expenses |
165,326,027.53 |
| Goodwill |
29,076,430.47 |
| Long-Term Deferred and Prepaid Expenses |
5,996,872.63 |
| Deferred Income Tax Assets |
80,825,408.00 |
| Other Non-Current Assets |
1,000,000.00 |
| Sub-Total of Non-Current Assets |
2,102,622,436.73 |
| Total Assets |
4,855,943,834.75 |
| Short-Term Loans |
251,914,859.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
758,451,795.04 |
| Accounts Received In Advance |
1,751,380.88 |
| Employee Compensation Payable |
32,328,511.56 |
| Taxes Payable |
142,267,260.07 |
| Interest Payable |
7,809,655.01 |
| Dividend Payable |
-- |
| Other payables |
213,166,758.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
485,381,467.03 |
| Other Current Liabilities |
2,524,569.40 |
| Sub-Total of Current Liabilities |
1,980,740,739.54 |
| Long-term Loans |
335,550,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
416,520,495.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
722,715,820.04 |
| Deferred Income Tax Liabilities |
14,321,734.81 |
| Other Non-Current Liabilities |
278,130.00 |
| Sub-Total of Non-Current Liabilities |
1,502,304,867.72 |
| Total Liabilities |
3,483,045,607.26 |
| Paid-In Capital(Or Share Stock) |
1,171,827,123.00 |
| Capital Surplus |
7,809,503,231.80 |
| Surplus Reserve |
32,669,182.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-7,536,536,840.19 |
| Minority Stockholder's Interest |
6,783,107.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,366,115,119.60 |
| Owner's Equity（Stockholder's Equity） |
1,372,898,227.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,855,943,834.75 |
